Principal Investigator and Co Sample Clauses

Principal Investigator and Co investigators
Sample 1Sample 2Sample 3See All (12)
AutoNDA by SimpleDocs
Principal Investigator and Co investigators 3.1 The Principal Investigator shall be supported in the execution of the Trial by the healthcare and non-healthcare personnel and by any contractors engaged by the Entity, as appointed by the Entity and operating under its responsibility for all aspects pertaining to this Trial, who are qualified to conduct the Trial, and who have previously received adequate training as provided for in the applicable laws, by the Sponsor/CRO, as applicable, and who have declared their willingness to take part in the Trial (the Co-investigators). Without affecting the foregoing, the definition of “Investigators” does not include any medical or non-medical personnel who perform ancillary institutional activities in the context of the Trial (for example hospital pharmacists who prepare the trial drugs). 3.2 The Parties acknowledge that the Entity and Principal Investigator is bound by all the responsibilities and obligations imposed on their role by the applicable regulations on clinical drug trials. 3.3 This Agreement is made between the Sponsor and the Entity. The Sponsor is extraneous to the relations between the Entity, the Principal Investigator and the Co-investigators, and is thus indemnified in respect of any claim that the personnel of the Entity involved in the Study may make in relation to the Trial. 3.4 In relation to the Trial, the Principal Investigator and the Co-investigators may not receive any direct or indirect compensation from the Sponsor, nor have any contact or dealings with the Sponsor or relations of any kind that are not of a technical or scientific nature. 3.5 If the relationship between the Principal Investigator and the Entity ends for any reason, the Entity will inform the Sponsor in writing and indicate the name of a replacement. The named replacement must be approved by the Sponsor and by the competent Ethics Committee. The Entity guarantees that the new Principal Investigator is qualified to continue the Trial, that they will accept the terms and conditions of this Agreement and that they will agree to respect the Protocol when executing the Trial. Pending approval of the substantial amendment for the change of Principal Investigator, the investigator indicated by the Sponsor shall carry out the necessary trial activities. If the Sponsor does not intend to accept the replacement proposed by the Entity, or if the Entity does not propose a substitute, the Sponsor may terminate this Agreement in accordance with the provisions of A...
Sample 1
Principal Investigator and Co investigators 3.1 The Principal Investigator shall be supported in the execution of the Trial by the healthcare and non- healthcare personnel and by any contractors engaged by the Entity, as appointed by the Entity and operating under its responsibility for all aspects pertaining to this Trial, who are qualified to conduct the Trial, and who have pre- viously received adequate training as provided for in the applicable laws, by the Sponsor/CRO and who have de- clared their willingness to take part in the Trial (the “Co- investigators”). Without affecting the foregoing, the def- inition of “Investigators” does not include any medical or non-medical personnel who perform proprietary institu- tional activities in the context of the Trial (for example hospital pharmacists who prepare the trial drugs). 3.2 The Parties acknowledge that the Principal Investiga- tor is bound by all the responsibilities and obligations im- posed on their role by the applicable regulations on clini- cal drug trials. 3.3 This Agreement is made between the Sponsor/CRO and the Entity. The Sponsor/CRO is extraneous to the re- lations between the Entity, the Principal Investigator and the Co-investigators, and is thus indemnified in respect of any claim that the personnel of the Entity involved in the Trial may make in relation to the Trial. 3.4 In relation to the Trial, the Principal Investigator and the Co-investigators may not receive any direct or indirect compensation from the Sponsor/CRO, nor have any con- tact or dealings with the Sponsor/CRO or relations of any kind that are not of a technical or scientific nature. 3.5 If the relationship between the Principal Investigator and the Entity ends for any reason, the Entity will inform Art. 3 - Sperimentatore principale e Co-sperimenta- tori 3.1 Lo Sperimentatore principale xxxx coadiuvato xxxx'ese- cuzione della Sperimentazione dal personale, sanitario e non sanitario, nonché da eventuali collaboratori incaricati dall’Ente stesso, designati dallo stesso e operanti sotto la sua responsabilità per gli aspetti relativi alla presente Spe- rimentazione, che sia qualificato per la conduzione della Sperimentazione, che abbia ricevuto preventivamente adeguata formazione prevista dalla normativa vigente dal Promotore/CRO e che abbia manifestato la propria dispo- nibilità a partecipare alla Sperimentazione (di seguito “Co-sperimentatori”). Fermo quanto precede, non rien- tra nella definizione di ‘Sperimentatori’ il personale me- dico e non med...
Sample 1

Related to Principal Investigator and Co

  • Principal Investigator The research will be under the direction of (“Principal Investigator”). If, for any reason, he/she is unable to continue to serve as Principal Investigator and a successor acceptable to both UHD and Sponsor is not available, this Agreement shall be terminated as provided in Section 7.

  • Investigator Where a difference arises between the parties relating to the dismissal, discipline or suspension of an employee, or to the interpretation, application, operation or alleged violation of this agreement, including any questions as to whether a matter is arbitrable, during the term of the collective agreement, an arbitrator agreed to by the parties shall, at the request of either party:

  • Project Team Cooperation Partnering 1.1.3 Constitutional Principles Applicable to State Public Works Projects.

  • Project Team To accomplish Owner’s objectives, Owner intends to employ a team concept in connection with the construction of the Project. The basic roles and general responsibilities of team members are set forth in general terms below but are more fully set forth in the Design Professional Contract with respect to the Design Professional, in the Program Management Agreement with any Program Manager, and in this Contract with respect to the Contractor.

  • Summer Students a) Summer Students shall not be employed while Employees on Seniority List A or B are on lay off in their respective trades.

  • Team Teaching Unit members participating in team teaching assignments will receive formula hour credit in proportion to the percentage of in-class involvement. When team-taught class sizes exceed the normal, the formula conditions specified in Section 4.3.3 shall apply.

  • Research, Science and Technology Cooperation 1. The aims of cooperation in research, science and technology, carried out in the mutual interest of the Parties and in compliance with their policies, will be: (a) to build on existing agreements already in place for cooperation on research, science and technology; (b) to encourage, where appropriate, government agencies, research institutions, universities, private companies and other research organizations in the Parties to conclude direct arrangements in support of cooperative activities, programs or projects within the framework of this Agreement, specially related to trade and commerce; and (c) to focus cooperative activities towards sectors where mutual and complementary interests exist, with special emphasis on information and communication technologies and software development to facilitate trade between the Parties. 2. The Parties will encourage and facilitate, as appropriate, the following activities including, but not limited to:

  • PROFESSORS, TEACHERS AND RESEARCHERS 1. An individual who is a resident of a Contracting State immediately before making a visit to the other Contracting State, and who, at the invitation of any university, college, school or other similar educational institution which is recognized by the competent authority in that other Contracting State, visits that other Contracting State for a period not exceeding two years solely for the purpose of teaching or research or both at such educational institution shall be exempt from tax in that other Contracting State on any remuneration for such teaching or research.

  • Drug-Free Workplace Contractor represents and warrants that it shall comply with the applicable provisions of the Drug-Free Work Place Act of 1988 (41 U.S.C. §701 et seq.) and maintain a drug-free work environment.

  • Potential Investor’s Representative The Potential Investor, if any, has appointed the Potential Investor’s Representative, if any, identified above, as Potential Investor’s broker or other intermediary with respect to the purchase of the Property. The Potential Investor agrees to pay out of Potential Investor’s own funds all brokerage fees, finder's fees or any other compensation claimed by the Potential Investor’s Representative or any broker or intermediary other than JLL in connection with Potential Investor’s interest in or proposed or actual purchase of the Property or any interest therein. The Potential Investor’s Representative, if any, by signing below, agrees to be bound by all the terms and conditions of this Agreement whether stated as obligations of the Potential Investor or a Related Party under the terms and conditions of this Agreement. The Potential Investor’s Representative, if any, further agrees by signing below that it will not look to the Owner, JLL or any Owner/JLL Related Party for any brokerage commissions, finder's fee or any other compensation claimed in connection with the sale of the Property or any interest therein to the Potential Investor or any other party (whether or not consummated for any reason). The Potential Investor's Representative, if any, by its signature hereto agrees herewith that its authorization to act in any capacity with respect to the purchase of the Property is limited to representing the Potential Investor and agrees that it will not discuss or exchange any information regarding the Property with any party other than the Potential Investor. Potential investor and Potential Investor’s Representative, if any, by its signature hereto agree to hold JLL and Owner, its officers, directors, partners, employees, agents, representatives, and any of their affiliates, beneficiaries, successors, and assigns harmless from, and shall indemnify and defend them against any and all fines, losses, damages suites, claims actions, demands, liabilities, costs and expenses (including court costs and attorney’s fees) of any kind, nature or character (collectively, the “Claims”), in connection with, related to, resulting from or arising or alleged to have arisen in connection with the Potential Investor’s Representative’s actions.

Time is Money Join Law Insider Premium to draft better contracts faster.